Price Chart

Profile

Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers.  The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.
URL https://www.adagene.com
Investor Relations URL N/A
HQ State/Province N/A
Sector Health Care
Industry Biotechnology
Equity Style N/A
Next Earnings Release Mar. 28, 2025 (est.)
Last Earnings Release Jul. 25, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers.  The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.
URL https://www.adagene.com
Investor Relations URL N/A
HQ State/Province N/A
Sector Health Care
Industry Biotechnology
Equity Style N/A
Next Earnings Release Mar. 28, 2025 (est.)
Last Earnings Release Jul. 25, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A